Saturday, October 16, 2021

Latest:

AI will improve healthcare, but doctors and patients need legal safety net
PBRM1’s new function supports a novel cancer-promoting mechanism
Resonance podcast: What are the health hazards of space travel?
It’s all in the delivery – Antibodies improve nanoparticle delivery of therapeutic nucleic acids
Tips for recovery after breast reconstruction surgery

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

endocrine resistant breast cancer

From The Labs

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020January 16, 2020 Ana Rodríguez 0 Comments endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen

From the Labs features an image of the three essential elements of plant life, winner of the 2021 Nikon’s Small World Photomicrography Competition. Image courtesy of J. Kirk/ Baylor's Optical Imaging & Vital Microscopy Core Lab.